Comparable stake leader
BlackRock, Inc.
SEC ownership of GILEAD SCIENCES, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000882095.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Public ticker
- GILD on Nasdaq
- Parsed ownership sources
-
13F and 13D/G
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000882095
- Issuer location
- Foster City, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of GILEAD SCIENCES, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13F
13D/G
Lead comparable stake: 8.2%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 8.2%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
8.2%
VANGUARD CAPITAL MANAGEMENT LLC
7.5%
FMR LLC
5.3%
Capital World Investors
4.3%
STATE STREET CORP
4.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
8.2%
from 13D/G
|
$16,586,559,275
119,010,973 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.5%
|
$13,007,001,690
93,327,127 shares
|
$0 | 31 Mar 2026 |
| FMR LLC |
13F
13D/G
Company
|
5.3%
from 13D/G
|
$10,021,579,771
71,906,290 shares
|
— | 31 Mar 2026 |
| Capital World Investors |
13F
13D/G
Company
|
4.3%
from 13D/G
|
$5,753,020,069
41,283,933 shares
|
— | 31 Mar 2026 |
| STATE STREET CORP |
13F
Company
|
4.8%
|
$8,342,490,991
59,858,585 shares
|
— | 31 Mar 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
2.8%
|
$4,895,993,537
35,129,465 shares
|
— | 31 Mar 2026 |
| JPMORGAN CHASE & CO |
13F
Company
|
2.7%
|
$4,634,525,446
33,992,410 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.4%
|
$4,135,590,576
29,726,052 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$79,870,148.
Buys
$0
Insiders: 0
Sells
$79,870,148
Insiders: 6
Net
-$79,870,148
Shares: -600,037
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 600,037
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 78,000 | $0 | $10,298,348 | -$10,298,348 |
| 3-6 | 0 | 309,280 | $0 | $44,068,700 | -$44,068,700 |
| 6-9 | 0 | 136,257 | $0 | $16,723,695 | -$16,723,695 |
| 9-12 | 0 | 76,500 | $0 | $8,779,405 | -$8,779,405 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 22 reporting-owner rows connected to GILEAD SCIENCES, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
22
Largest Forms 3/4/5 holder
Daniel Patrick O'Day
Net 12M change
-$79,870,148
Latest report
15 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Daniel Patrick O'Day | Chairman & CEO, Director | $100,695,455 | -$48,640,146 | -33% | Mixed | 10 Jun 2026 |
| Andrew D. Dickinson | Chief Financial Officer | $26,049,769 | -$4,296,900 | -14% | Mixed | 15 Jun 2026 |
| Johanna Mercier | Chief Comm & Corp Aff Officer | $20,173,927 | -$17,837,829 | -47% | Mixed | 15 Jun 2026 |
| Merdad Parsey | Chief Medical Officer | $13,940,850 | Mixed | 10 Dec 2024 | ||
| Deborah H. Telman | EVP, Corporate Affairs & GC | $9,143,992 | -$6,590,487 | -42% | Mixed | 12 Nov 2025 |
| Olsen Per Wold | Director | $8,754,707 | Mixed | 06 May 2021 | ||
| Dietmar Berger | Chief Medical Officer | $8,668,846 | Mixed | 10 Jun 2026 | ||
| Sandra C. Patterson | SVP, Controllership | $6,811,146 | Mixed | 10 Mar 2025 | ||
| Diane E. Wilfong | Interim Corp Controller & CAO | $5,331,349 | Mixed | 10 Sep 2025 | ||
| Brett A. Pletcher | EVP,Corp Affairs & Gen Counsel | $4,172,613 | Mixed | 10 Jun 2022 | ||
| Jacqueline K. Barton | Director | $3,791,142 | Median | 30 Apr 2026 | ||
| Richard James Whitley | Director | $3,154,008 | Mixed | 06 May 2021 | ||
| Harish Manwani | Director | $2,092,640 | Median | 30 Apr 2026 | ||
| Javier Rodriguez | Director | $1,862,540 | Median | 30 Apr 2026 | ||
| Anthony S. Welters | Director | $1,797,036 | Median | 30 Apr 2026 | ||
| Jeffrey A. Bluestone | Director | $1,402,898 | -$1,791,600 | -56% | Median | 30 Apr 2026 |
| Sandra Horning | Director | $1,386,226 | Mixed | 30 Apr 2026 | ||
| Ted W. Love | Director | $764,305 | Median | 30 Apr 2026 | ||
| Keeley M. Cain Wettan | EVP Gen Counsel, Legal & Comp | $747,023 | Median | 10 Jun 2026 | ||
| Kelly A. Kramer | Director | $170,186 | -$713,186 | -81% | Filing P/S | 30 Apr 2026 |
Recent insider transactions for GILEAD SCIENCES, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Johanna Mercier | GILD | Common Stock | Sale | -2.36% | $371,762 | $123.92 | -3,000 | 124,234 | 15 Jun 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Sale | -1.72% | $376,200 | $125.40 | -3,000 | 171,646 | 15 Jun 2026 | Direct |
| Dietmar Berger | GILD | Common Stock | Tax liability | -1.35% | -263 | 19,252 | 10 Jun 2026 | Direct | ||
| Dietmar Berger | GILD | Common Stock | Options Exercise | 2.81% | 533 | 19,515 | 10 Jun 2026 | Direct | ||
| Dietmar Berger | GILD | Restricted Stock Unit | Options Exercise | -1.12% | -533 | 46,928 | 10 Jun 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Common Stock | Tax liability | -5.02% | -283 | 5,360 | 10 Jun 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Common Stock | Options Exercise | 11.6% | 589 | 5,643 | 10 Jun 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Restricted Stock Unit | Options Exercise | -2.86% | -589 | 19,997 | 10 Jun 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Common Stock | Tax liability | -0.76% | -1,341 | 174,646 | 10 Jun 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Common Stock | Options Exercise | 1.61% | 2,796 | 175,987 | 10 Jun 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Restricted Stock Unit | Options Exercise | -9.12% | -2,796 | 27,851 | 10 Jun 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Tax liability | -1.04% | -1,341 | 127,234 | 10 Jun 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Options Exercise | 2.22% | 2,796 | 128,575 | 10 Jun 2026 | Direct | ||
| Johanna Mercier | GILD | Restricted Stock Unit | Options Exercise | -9.12% | -2,796 | 27,851 | 10 Jun 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Common Stock | Tax liability | -0.67% | -4,213 | 622,133 | 10 Jun 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Common Stock | Options Exercise | 1.42% | 8,779 | 626,346 | 10 Jun 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Restricted Stock Unit | Options Exercise | -8.7% | -8,779 | 92,080 | 10 Jun 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Common Stock | Sale | -2.37% | $1,971,847 | $131.46 | -15,000 | 617,567 | 01 Jun 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Sale | -1.7% | $396,810 | $132.27 | -3,000 | 173,191 | 15 May 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Sale | -18.2% | $3,676,199 | $131.29 | -28,000 | 125,779 | 15 May 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Options Exercise | 19.4% | 25,000 | 153,779 | 15 May 2026 | Direct | ||
| Johanna Mercier | GILD | Non-qualified Stock Option (Right to Buy) | Options Exercise | -52% | -25,000 | 23,110 | 15 May 2026 | Direct | ||
| Jeffrey A. Bluestone | GILD | Common Stock | Award | 12.8% | 1,146 | 10,066 | 30 Apr 2026 | Direct | ||
| Jeffrey A. Bluestone | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Jacqueline K. Barton | GILD | Common Stock | Award | 4.4% | 1,146 | 27,202 | 30 Apr 2026 | Direct | ||
| Jacqueline K. Barton | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Sandra J. Horning | GILD | Common Stock | Award | 22.3% | 1,146 | 6,293 | 30 Apr 2026 | Direct | ||
| Sandra J. Horning | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Ted W. Love | GILD | Common Stock | Award | 26.4% | 1,146 | 5,484 | 30 Apr 2026 | Direct | ||
| Ted W. Love | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Javier J. Rodriguez | GILD | Common Stock | Award | 9.38% | 1,146 | 13,364 | 30 Apr 2026 | Direct | ||
| Javier J. Rodriguez | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Anthony Welters | GILD | Common Stock | Award | 9.75% | 1,146 | 12,894 | 30 Apr 2026 | Direct | ||
| Anthony Welters | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Harish Manwani | GILD | Common Stock | Tax liability | -1.47% | -224 | 15,015 | 30 Apr 2026 | Direct | ||
| Harish Manwani | GILD | Common Stock | Award | 8.13% | 1,146 | 15,239 | 30 Apr 2026 | Direct | ||
| Harish Manwani | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Kelly A. Kramer | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Kelly A. Kramer | GILD | Restricted Stock Unit | Award | 6% | 1,146 | 20,256 | 30 Apr 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Common Stock | Sale | -1.56% | $1,291,608 | $129.16 | -10,000 | 632,567 | 28 Apr 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Sale | -1.67% | $422,880 | $140.96 | -3,000 | 176,191 | 15 Apr 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Sale | -2.28% | $422,880 | $140.96 | -3,000 | 128,779 | 15 Apr 2026 | Direct |
| Daniel Patrick O'Day | GILD | Common Stock | Sale | -1.53% | $1,368,162 | $136.82 | -10,000 | 642,567 | 27 Mar 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Sale | -2.23% | $432,690 | $144.23 | -3,000 | 131,779 | 16 Mar 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Sale | -1.65% | $432,690 | $144.23 | -3,000 | 179,191 | 16 Mar 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Tax liability | -1.7% | -3,147 | 182,191 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Common Stock | Options Exercise | 3.62% | 6,469 | 185,338 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Non-qualified Stock Option (Right to Buy) | Award | 35,880 | 35,880 | 10 Mar 2026 | Direct | |||
| Andrew D. Dickinson | GILD | Restricted Stock Unit | Award | 45.5% | 9,590 | 30,647 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Restricted Stock Unit | Options Exercise | -23.5% | -6,469 | 21,057 | 10 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.